VIEWPOINTSPharmaShots Interview: Entrada’s Dipal Doshi Shares Insights on the Series B Funding Utilize to Advance DMD Program into the ClinicBySenior EditorMay 19, 20210Comments
VIEWPOINTSPharmaShots Interview: GCCA’s Andrew Spiegel Shares Insights on the Clear Your View CampaignBySenior EditorMay 18, 20210Comments
VIEWPOINTSPharmaShots Interview: Women First Digital’s Sneha Nair and Claire Crossett Share Insights on the Launch of World’s First Abortion Virtual Assistant, Ally on WhatsAppBySenior EditorMay 17, 20210Comments
VIEWPOINTSPharmaShots Interview: Aceto’s Gilles Cottier Shares Insight on the Acquisition of A&C and IsleChemBySenior EditorMay 11, 20210Comments
VIEWPOINTSPharmaShots Interview: Ipsen’s Dr. Med. Steven Hildemann Shares Insight on the EC’s Approval of Cabometyx + Nivolumab for Advanced Renal Cell CarcinomaBySenior EditorMay 11, 20210Comments
VIEWPOINTSPharmaShots Interview: Amolyt Pharma’s Thierry Abribat Shares Insight on AZP-3601 for HypoparathyroidismBySenior EditorMay 10, 20210Comments
VIEWPOINTSPharmaShots Interview: J&J’s Sven Sjovall & Dr. Mark Watt Share Insight on Nicorette’s Latest Digital Smoking Cessation OfferingBySenior EditorMay 5, 20210Comments
VIEWPOINTSPharmaShots Interview: Dr. Drew Falconer Shares Insights on the Abbott’s NeuroSphere Virtual ClinicBySenior EditorMay 3, 20210Comments
